PDE4B and Cognitive impairment: These results suggest that A33 ameliorates cognitive impairment of AlD by reduction of Aβ burden, inhibition of microglial cells, and recovery of neurogenesis via PDE4B-mediated cAMP/PKA signaling (Figure S4).